Synthesis and Development of Indole Based 5-HT3 Receptor Antagonists as Anti-Emetic Drugs in Oncology :An Update

被引：2

作者：

Rivera-Fonseca, Johana L. ^{[1
,2
]}

Gonzalez-Rivas, Nelly ^{[1
,2
]}

Basavanag Unnamatla, M., V ^{[1
,2
]}

Garcia-Eleno, Marco A. ^{[1
,2
]}

Reyes, Horacio ^{[3
]}

German Lopez-Valdez, L. ^{[4
]}

Corona-Becerril, David ^{[1
,2
]}

Cuevas-Yanez, Erick ^{[1
,2
]}

机构：

[1] UAEM UNAM, Ctr Conjunto Invest Quim Sustentable, Carretera Toluca Atlacomulco Km 14-5, Toluca 50200, Estado De Mexic, Mexico

[2] Univ Autonoma Estado Mexico, Fac Quim, Toluca 50120, Mexico

[3] Tecnol Estudios Super Jocotitlan, Div Ingn Quim, Carretera Toluca Atlacomulco Km 44-8, Jocotitlan, Edo, Mexico

[4] Univ Autonoma Chapingo, Dept Preparatoria Agr, Area Quim, Lab Prod Nat, Apartado 74,Km 38-5 Carretera Mexico Texcoco, Chapingo 56230, Mexico

来源：

CURRENT MEDICINAL CHEMISTRY | 2021年 / 28卷 / 42期

关键词：

Antiemetic drugs; 5-HT3; indole; synthesis; ondansetron; ramosetron; dolasetron; granisetron; ricaset-ron; tropisetron; CHEMOTHERAPY-INDUCED NAUSEA; IRRITABLE-BOWEL-SYNDROME; INDUCED EMESIS; 5-HYDROXYTRYPTAMINE(3) RECEPTORS; PHARMACOLOGICAL PROFILE; POSTOPERATIVE NAUSEA; ANTICIPATORY NAUSEA; THERAPEUTIC AGENT; CHRONIC TOXICITY; VOMITING CINV;

D O I：

10.2174/0929867328666210708091134

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

An important group of antiemetic drugs used in the treatment of nausea and vomiting after chemotherapy containing an indole moiety in their structures, working as 5hydroxytryptamine type 3 serotonin receptor antagonist (5-HT3). This study focuses on compounds bearing an indole core that present a 5-HT3 receptor antagonist activity, which have been successfully used as antiemetic drugs for reducing chemotherapy adverse secondary effects during cancer treatment. Their synthesis, biological activities, and some outstanding characteristics are discussed, providing a general outlook towards the development of more efficient antiemetic drugs.

引用

页码：8733 / 8754

页数：22

共 50 条

[1] 5-HT3 RECEPTORS IN THE AREA POSTREMA MAY MEDIATE THE ANTI-EMETIC EFFECTS OF 5-HT3 ANTAGONISTS IN THE FERRET
HIGGINS, GA
KILPATRICK, GJ
BUNCE, KT
JONES, BJ
TYERS, MB
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 : P504 - P504
[2] SYNTHESIS OF INDOLE OXAZOLINES - NOVEL 5-HT3 ANTAGONISTS
SWAIN, CJ
KNEEN, C
HERBERT, R
BAKER, R
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1990, (11): : 3183 - 3186
[3] SYNTHESIS OF INDOLE OXAZOLINES, POTENT 5-HT3 ANTAGONISTS
SWAIN, CJ
KNEEN, C
BAKER, R
TETRAHEDRON LETTERS, 1990, 31 (17) : 2445 - 2448
[4] 5-HT3 receptor antagonists
Silverstone, PH
Greenshaw, AJ
EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (05) : 471 - 481
[5] 5-HT3 receptor antagonists
Lloyd, AW
DRUG DISCOVERY TODAY, 1997, 2 (05) : 206 - 206
[6] NOVEL 5-HT3 ANTAGONISTS - INDOLE OXADIAZOLES
SWAIN, CJ
BAKER, R
KNEEN, C
MOSELEY, J
SAUNDERS, J
SEWARD, EM
STEVENSON, G
BEER, M
STANTON, J
WATLING, K
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 140 - 151
[7] A PHARMACOKINETIC STUDY OF GRANISETRON (BRL 43694A), A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST - CORRELATION WITH ANTI-EMETIC RESPONSE
CARMICHAEL, J
CANTWELL, BMJ
EDWARDS, CM
ZUSSMAN, BD
THOMPSON, S
RAPEPORT, WG
HARRIS, AL
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (01) : 45 - 49
[8] Improved Anti-Emetic Efficacy of 5-HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter
Zoto, Teuta
Kilickap, Saadettin
Yasar, Umit
Celik, Ismail
Bozkurt, Atilla
Babaoglu, Melih Onder
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (04) : 354 - 360
[9] 5-HT3 RECEPTORS AND THE THERAPEUTIC POTENTIAL OF 5-HT3 RECEPTOR ANTAGONISTS
TYERS, MB
THERAPIE, 1991, 46 (06): : 431 - 435
[10] THE DEVELOPMENT OF SELECTIVE 5-HT3 RECEPTOR ANTAGONISTS AS ANTIEMETIC AGENTS
SANGER, GJ
BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 479 - 479

← 1 2 3 4 5 →